1. Home
  2. ABP vs AEI Comparison

ABP vs AEI Comparison

Compare ABP & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • AEI
  • Stock Information
  • Founded
  • ABP 2004
  • AEI 2014
  • Country
  • ABP United States
  • AEI United States
  • Employees
  • ABP N/A
  • AEI N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • AEI Building operators
  • Sector
  • ABP Health Care
  • AEI Real Estate
  • Exchange
  • ABP Nasdaq
  • AEI Nasdaq
  • Market Cap
  • ABP 12.3M
  • AEI 13.6M
  • IPO Year
  • ABP N/A
  • AEI N/A
  • Fundamental
  • Price
  • ABP $0.27
  • AEI $1.34
  • Analyst Decision
  • ABP Strong Buy
  • AEI
  • Analyst Count
  • ABP 1
  • AEI 0
  • Target Price
  • ABP $4.00
  • AEI N/A
  • AVG Volume (30 Days)
  • ABP 16.7M
  • AEI 76.5K
  • Earning Date
  • ABP 08-13-2025
  • AEI 08-26-2025
  • Dividend Yield
  • ABP N/A
  • AEI N/A
  • EPS Growth
  • ABP N/A
  • AEI N/A
  • EPS
  • ABP N/A
  • AEI N/A
  • Revenue
  • ABP $183,000.00
  • AEI $16,069,911.00
  • Revenue This Year
  • ABP N/A
  • AEI N/A
  • Revenue Next Year
  • ABP N/A
  • AEI N/A
  • P/E Ratio
  • ABP N/A
  • AEI N/A
  • Revenue Growth
  • ABP 154.17
  • AEI 74.28
  • 52 Week Low
  • ABP $0.15
  • AEI $0.70
  • 52 Week High
  • ABP $11.19
  • AEI $2.61
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • AEI 61.43
  • Support Level
  • ABP N/A
  • AEI $1.16
  • Resistance Level
  • ABP N/A
  • AEI $1.23
  • Average True Range (ATR)
  • ABP 0.00
  • AEI 0.09
  • MACD
  • ABP 0.00
  • AEI -0.01
  • Stochastic Oscillator
  • ABP 0.00
  • AEI 70.49

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About AEI Alset Inc. (TX)

Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.

Share on Social Networks: